Janus Henderson Group PLC Increases Stock Holdings in Astera Labs, Inc. $ALAB

Janus Henderson Group PLC lifted its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 3,696.4% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 433,165 shares of the company’s stock after buying an additional 421,755 shares during the period. Janus Henderson Group PLC’s holdings in Astera Labs were worth $47,414,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of ALAB. Reflection Asset Management acquired a new position in shares of Astera Labs during the 4th quarter worth approximately $25,000. Smartleaf Asset Management LLC increased its stake in shares of Astera Labs by 422.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after acquiring an additional 152 shares during the last quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA acquired a new position in shares of Astera Labs in the 4th quarter valued at $33,000. Whipplewood Advisors LLC grew its position in Astera Labs by 15,950.0% during the first quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock valued at $35,000 after acquiring an additional 319 shares during the period. Finally, Assetmark Inc. increased its position in Astera Labs by 78.9% during the 4th quarter. Assetmark Inc. now owns 229 shares of the company’s stock worth $38,000 after purchasing an additional 101 shares in the last quarter. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Astera Labs Stock Up 3.9%

ALAB stock opened at $311.23 on Friday. The stock has a market cap of $53.35 billion, a PE ratio of 210.29, a price-to-earnings-growth ratio of 3.61 and a beta of 3.66. The firm’s 50-day simple moving average is $359.97 and its 200 day simple moving average is $229.78. Astera Labs, Inc. has a fifty-two week low of $97.89 and a fifty-two week high of $499.48.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The firm had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. During the same quarter in the prior year, the firm earned $0.33 EPS. Astera Labs’s quarterly revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities analysts forecast that Astera Labs, Inc. will post 1.86 EPS for the current fiscal year.

Insider Buying and Selling

In related news, COO Sanjay Gajendra sold 400,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 21st. The stock was sold at an average price of $290.30, for a total value of $116,120,000.00. Following the sale, the chief operating officer directly owned 5,064,213 shares in the company, valued at $1,470,141,033.90. This trade represents a 7.32% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 136,974 shares of the firm’s stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $442.01, for a total value of $60,543,877.74. Following the transaction, the director directly owned 1,287,524 shares in the company, valued at $569,098,483.24. This trade represents a 9.62% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,676,845 shares of company stock valued at $444,928,806 in the last three months. 10.40% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

ALAB has been the topic of a number of analyst reports. UBS Group lifted their price objective on shares of Astera Labs from $205.00 to $400.00 and gave the company a “neutral” rating in a research note on Monday, June 29th. Roth Capital reiterated a “buy” rating and issued a $275.00 price target on shares of Astera Labs in a research note on Wednesday, May 6th. Rothschild & Co Redburn started coverage on Astera Labs in a report on Friday, May 1st. They issued a “neutral” rating and a $153.00 price objective for the company. Needham & Company LLC upped their price objective on Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a research note on Wednesday, May 6th. Finally, Weiss Ratings raised Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, May 21st. Thirteen research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $284.25.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.